Novartis AS | 85.8000 / -3.28% |
Date/Time | 02/24 / 18:35 |
Chg. / Chg.(%) | -2.9054 / -3.28% |
Bid | - |
Ask | - |
Open | 87.1000 |
Previous Close | 88.7054 |
High | 87.1000 |
Low | 85.8000 |
Volume [USD] | 205,658.3000 |
Volume [Units] | 2,716 |
Price fixings | 5 |
ISIN | CH0012005267 |
Security | NVSEF |
Exchange | Nasdaq Other OTC |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
London Inter.. | 79.54 | ![]() |
2,785,918 |
SIX Swiss Ex.. | 79.55 | ![]() |
2,056,763 |
Cboe Europe .. | 79.47 | ![]() |
152,439 |
Cboe Europe .. | 79.48 | ![]() |
107,889 |
Turquoise | 79.49 | ![]() |
40,264 |
Lang & Schwa.. | 71.540 | ![]() |
|
Nasdaq Other.. | 85.8000 | ![]() |
2,716 |
TradeGate | 80.000 | 16,350 | |
Frankfurt | 80.1600 | 1,589 | |
Borsa Italia.. | 79.20 | 1,042 | |
Hamburg | 80.19 | 1,000 | |
München | 80.10 | 55 | |
Berlin | 80.40 | 40 | |
gettex | 80.160 | 20 | |
Düsseldorf | 80.18 | 4 | |
Hannover | 80.10 | 0 | |
Borsa Italia.. | 75.00 | 36 | |
EUREX | Options |
News
- Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos
14:00 - GlobeNewswire - Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results
13:30 - GlobeNewswire - Novartis Entresto® granted expanded indication in chronic heart failure by FDA
02/16/2021 / 19:22 - GlobeNewswire - Novartis signs initial deal to manufacture Pfizer jabs
01/29/2021 / 13:04 - TeleTrader - Novartis Sees 6-Figure Savings with Qlik
01/26/2021 / 14:30 - GlobeNewswire